Key result
Peritoneal dialysis relieves refractory heart failure symptoms but carries fatal risks from recurrent peritonitis.
Why the study?
Treatment options for patients with intractable congestive heart failure resistant to all other therapies are limited.
Case Report (n=3)
Answers are grounded in this paper and cite their sources.
Should not yet change practice in refractory HF; leaves open whether peritoneal dialysis can be delivered safely without infectious complications.
Three patients with intractable congestive heart failure (CHF) resistant to all other therapy were treated for three, five and six months by continuous ambulatory peritoneal dialysis (CAPD). They lost eight to II kg in weight and had a marked improvement in symptoms of heart failure. Recurrent peritonitis precluded the continuation of CAPD and all three patients died within two weeks of stopping the treatment.
No takes yet. Share an insight, caveat, or question.
Boleswar et al. (1983) conducted a case report in Intractable congestive heart failure (n=3). Continuous ambulatory peritoneal dialysis (CAPD) was evaluated on Weight loss and heart failure symptoms. Continuous ambulatory peritoneal dialysis improved symptoms and induced 8-11 kg weight loss in 3 patients with refractory heart failure, but recurrent peritonitis led to treatment cessation and death.
Synapse has enriched 10 related papers. Consider them for comparative context: